LouisACannonMDFACC,FACP,FACA,FSCAI

Cardiology • Petoskey, MI

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Assistant Professor, Internal Medicine, Oakland University Wm Beaumont SOM

Join to view full profile

Dr. Cannon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cannon's full profile

Already have an account?

Office
560 W Mitchell St
Ste 400
Petoskey, MI 49770
Phone+1 231-487-2490

Fax+1 231-487-6055

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Cardiovascular Disease, 1988 - 1991
Akron General Medical Center/NEOMEDResidency, Internal Medicine, 1984 - 1988
Wright State University Boonshoft School of MedicineClass of 1984

Certifications & Licensure

MI State Medical License 1991 - 2025
FL State Medical License 2013 - 2020
OH State Medical License 1985 - 2007
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2013
Fellow (FACC) American College of Cardiology

Clinical Trials

TAXUS PERSEUS Workhorse Start of enrollment: 2007 Jul 01
Completed
Phase 3
TAXUS PERSEUS Small Vessel Start of enrollment: 2007 Jul 01
Completed
Phase 3
ION US Post-Approval Study Start of enrollment: 2011 Sep 01
Completed
ABSORB III Randomized Controlled Trial (RCT) Start of enrollment: 2012 Dec 01
Completed
Not Applicable
BioFreedom US IDE Feasibility Trial Start of enrollment: 2014 Aug 01
Unknown status
Phase 2, Phase 3
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions Start of enrollment: 2014 May 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

26 citations
Diphenhydramine-induced toxic psychosis
Jeffrey Jones, James Dougherty, Louis Cannon
The American Journal of Emergency Medicine. 1986-07-01
19 citations
Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions
Paul S. Teirstein, Ian T Meredith, Robert L. Feldman, A. Charles Rabinowitz, Louis Cannon
Catheterization and Cardiovascular Interventions. 2015-02-01
597 citations
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
Gregg W. Stone, Stephen G. Ellis, Louis Cannon, J. Tift Mann, Joel Greenberg
JAMA. 2005-09-14

Lectures

Telerobotics in Stroke and AMI Intervention: Afar Is Not Far-Reaching Anymore!
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019

Press Mentions

Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in ResidenceMay 25th, 2021
Mark Toland, Former CEO of Siemens-Owned Corindus, Joins BioStar Capital as Partner and Entrepreneur in ResidenceSeptember 15th, 2020

Professional Memberships

American College of Cardiology - ACC
Member